TNF and obesity disorder: First, we observed that obesity was associated with a 60% higher odds of failing anti-TNF therapy as compared to non-obese and normal BMI counterparts, for most IMIDs, including RA, spondyloarthropathies and psoriasis and psoriatic arthritis, but not IBD.